Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance

Rivadeneira et al.

  • Immunity
  • September 2019

Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

Kudo et al.

  • Annals of Oncology
  • September 2019

Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy

Shah et al.

  • Blood Advances
  • August 2019

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor- induced encephalitis

Johnson et al.

  • Nature Medicine
  • July 2019

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Wang et al.

  • Nature Immunology
  • July 2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Kuehm et al.

  • Cancer Immunology and Immunotherapy
  • May 2019

Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing

Sankin et al.

  • Urologic Oncology
  • May 2019

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Voorwerk et al.

  • Nature Medicine
  • May 2019

Rational design of anti-GITR-based combination immunotherapy

Zappasodi et al.

  • Nature Medicine
  • April 2019